Clinical Trial Update: Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms [Phase 2]

View source ↗

Summary

Phase 2 trial comparing FLOMAX (tamsulosin) to placebo in women with lower urinary tract symptoms focusing on voiding symptoms; the study status shows completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms

Drugs mentioned

• Flomax (tamsulosin hydrochloride)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Lower Urinary Tract Symptoms | Phase 2 | Status: COMPLETED